Article Details
Retrieved on: 2022-03-24 14:19:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca shared that using imfinzi alongside chemoradiotherapy did not meet statistical significance in improving progression-free survival ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here